Dataset Information


Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.

ABSTRACT: To determine the effects of statins on vascular function, inflammation, and androgen levels in women with polycystic ovary syndrome (PCOS), we randomized 20 women with PCOS who had low-density lipoprotein cholesterol levels >100 mg/dL to atorvastatin (40 mg/day) or placebo for 6 weeks and found that atorvastatin reduced androgen levels, biomarkers of inflammation, and blood pressure; increased insulin levels and brachial artery conductance during reactive hyperemia; and failed to improve brachial artery flow-mediated dilation. We conclude that until additional studies demonstrate a clear risk-to-benefit ratio favoring statin therapy in PCOS, statins should only be used in women with PCOS who meet current indications for statin treatment.


PROVIDER: S-EPMC3062732 | BioStudies | 2011-01-01


REPOSITORIES: biostudies

Similar Datasets

2009-01-01 | S-EPMC2673911 | BioStudies
2018-01-01 | S-EPMC5854850 | BioStudies
2011-01-01 | S-EPMC5357054 | BioStudies
2009-01-01 | S-EPMC2671099 | BioStudies
2016-01-01 | S-EPMC4741209 | BioStudies
2020-01-01 | S-EPMC7132972 | BioStudies
2017-01-01 | S-EPMC5379546 | BioStudies
2016-01-01 | S-EPMC5226288 | BioStudies
2020-01-01 | S-EPMC7112974 | BioStudies
2010-01-01 | S-EPMC3035518 | BioStudies